Endocrine related immune adverse events associated with programmed death ligand-1 (PD-L1) therapy in hematologic malignancies: A retrospective analysis
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI